Lexeo Therapeutics, Inc. (LXEO) Total liabilities

Lexeo Therapeutics, Inc. (LXEO) total liabilities at each fiscal year-end, per SEC filings.

$25.0MFY2023

Fiscal year	Value	YoY
FY2023	$25.0M	—

Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.

Source: SEC XBRL filings · For reference only · Not investment advice

More LXEO financial trends

LXEO Revenue LXEO Net income LXEO Net margin LXEO Gross profit LXEO Gross margin LXEO Operating income LXEO Operating margin LXEO Operating cash flow LXEO Free cash flow LXEO Capital expenditures LXEO Return on equity LXEO Stock buybacks LXEO Dividends paid LXEO Total assets LXEO Shareholders’ equity LXEO overview →